JP2022512651A5 - - Google Patents

Info

Publication number
JP2022512651A5
JP2022512651A5 JP2021519660A JP2021519660A JP2022512651A5 JP 2022512651 A5 JP2022512651 A5 JP 2022512651A5 JP 2021519660 A JP2021519660 A JP 2021519660A JP 2021519660 A JP2021519660 A JP 2021519660A JP 2022512651 A5 JP2022512651 A5 JP 2022512651A5
Authority
JP
Japan
Prior art keywords
molecule according
molecule
group
cancer
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021519660A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512651A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/055394 external-priority patent/WO2020076948A1/en
Publication of JP2022512651A publication Critical patent/JP2022512651A/ja
Publication of JP2022512651A5 publication Critical patent/JP2022512651A5/ja
Pending legal-status Critical Current

Links

JP2021519660A 2018-10-09 2019-10-09 Ｒｉｇ－ｉアゴニストおよびそれを使用する方法 Pending JP2022512651A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862743387P 2018-10-09 2018-10-09
US62/743,387 2018-10-09
PCT/US2019/055394 WO2020076948A1 (en) 2018-10-09 2019-10-09 Rig-i agonists and methods of using same

Publications (2)

Publication Number Publication Date
JP2022512651A JP2022512651A (ja) 2022-02-07
JP2022512651A5 true JP2022512651A5 (enExample) 2022-10-12

Family

ID=70163870

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021519660A Pending JP2022512651A (ja) 2018-10-09 2019-10-09 Ｒｉｇ－ｉアゴニストおよびそれを使用する方法

Country Status (6)

Country Link
US (2) US20210230596A1 (enExample)
EP (1) EP3863675A4 (enExample)
JP (1) JP2022512651A (enExample)
CN (1) CN113164607A (enExample)
CA (1) CA3115294A1 (enExample)
WO (1) WO2020076948A1 (enExample)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9181551B2 (en) * 2002-02-20 2015-11-10 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
WO2004015075A2 (en) * 2002-08-08 2004-02-19 Dharmacon, Inc. Short interfering rnas having a hairpin structure containing a non-nucleotide loop
ES2911034T3 (es) * 2006-08-08 2022-05-17 Univ Bonn Rheinische Friedrich Wilhelms Estructura y uso de oligonucleótidos 5' fosfato
WO2013077446A1 (ja) * 2011-11-26 2013-05-30 株式会社ボナック 遺伝子発現制御のための一本鎖核酸分子
WO2014159990A1 (en) * 2013-03-13 2014-10-02 Yale University Interferon production using short rna duplexes
JP7366057B2 (ja) * 2018-04-19 2023-10-20 チェックメイト ファーマシューティカルズ， インコーポレイテッド 合成ｒｉｇ－ｉ様受容体アゴニスト
EP3810151B1 (en) * 2018-06-20 2025-08-06 Yale University Rig-i agonists and treatments using same

Similar Documents

Publication Publication Date Title
JP2021529173A5 (enExample)
US5631135A (en) Oligonucleotide N3'→P5' phosphoramidates: hybridization and nuclease resistance properties
CN109890207B (zh) 包含可逆修饰的寡核苷酸的组合物及其用途
CA2184375C (en) Oligonucleotide n3'-p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties
US5726297A (en) Oligodeoxyribonucleotide N3' P5' phosphoramidates
ES2302701T3 (es) N3'-p5' tiofosforamidatos oligonucleotidicos: su sintesis y uso.
JP5540312B2 (ja) 環状１本鎖核酸複合体およびその製造方法
JP2005517452A5 (enExample)
RU2015119409A (ru) Конъюгаты олигонуклеотидов
JP2007529224A5 (enExample)
JP2005524393A5 (enExample)
MX9703192A (es) Nucleosidos modificados en el azucar y su uso para la sintesis de oligonucleosidos.
RU2014121304A (ru) Ингибирование экспрессии вирусных генов
JP2014532400A (ja) 免疫賦活用の二本鎖ｒｎａ
ES3030929T3 (en) Arnatar compounds and methods for enhanced cellular uptake
JP2018109015A (ja) 三環ヌクレオシドおよびこれらから調製したオリゴマー化合物
WO2023049218A1 (en) Double stranded oligonucleotide compositions and methods relating thereto
US8247540B2 (en) Caged nucleotides and oligonucleotides and their application
JP2022512651A5 (enExample)
Seio et al. Synthesis and properties of cationic 2′-O-[N-(4-aminobutyl) carbamoyl] modified oligonucleotides
Grajkowski et al. Design and development of thermolytic DNA oligonucleotide prodrugs
Atsumi et al. Nucleosides and nucleotides. Part 214: thermal stability of triplexes containing 4′ α-C-Aminoalkyl-2′-deoxynucleosides
Osman et al. Synthesis of A New Intercalating Nucleic Acid 6 H-INDOLO [2, 3-b] Quinoxaline Oligonucleotides to Improve Thermal Stability Of Hoogsteen-Type Triplexes
RU2008121953A (ru) Ирнк-ингибирование репликации вируса гриппа
CN100482673C (zh) 使用免疫刺激性寡核苷酸和/或免疫子化合物结合细胞因子和/或化疗剂或放射治疗对免疫系统的协同刺激作用